ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Directors Cash Out as NVDA Director Dumps $411M

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

An NVIDIA board member has been one of the most active sellers in recent filings. Mark Stevens, an independent director at the $4.4 trillion chipmaker, filed disclosures showing he sold roughly 1.85 million shares across seven transactions between 31 August and 2 September, totalling approximately $411 million. That is a large exit even by Silicon Valley standards.

The scale dwarfs other activity in the same period. NVIDIA's General Counsel Timothy Teter also filed sales worth around $6.5 million on 31 August, adding to the pattern of outgoing stock at the top. Short interest in NVDA sits at just 1.3% of free float, so this is not a squeeze story. It is a pure signal-watching exercise: board-level sales of this size tend to draw attention regardless of company performance.

Elsewhere, argenx CEO Tim Van Hauwermeiren filed a sale of 20,000 shares worth $21 million on 5 September. Four insiders at the Belgian immunology company sold in the same two-week window, with combined proceeds topping $29 million.

At WuXi XDC, parent company WuXi AppTec offloaded 53.5 million shares worth $500 million on 31 August, filed 4 September. The biotech's COO Jerry Zhang also sold roughly $3.4 million in shares the same week. That combination of parent-company and C-suite selling arriving together is worth watching.

On the buying side, Shenzhou International Executive Chairman Ma Jianrong spent $25.8 million buying 5.6 million shares on 1 September. At Post Holdings, Chairman Emeritus William Stiritz sold $23.4 million worth of stock. Post carries a notably elevated short interest of 16.5% of free float.

Coherent Corp saw eight insiders file sales totalling $15.7 million, with no offsetting purchases recorded.

Stocks in this article

How this article was generated

Generated
7 Nov 2026, 04:12
Prompt version
v1.0
Data sources
Institutional positioningAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.